Bacillus Licheniformis Sales

Bacillus Licheniformis Sales Market Outlook

The global Bacillus Licheniformis market is projected to reach USD 1.5 billion by 2035, growing at a CAGR of 7.5% during the forecast period from 2025 to 2035. The increasing demand for natural and sustainable products across various industries such as agriculture, food & beverage, and pharmaceuticals is driving the growth of this market. Bacillus Licheniformis is known for its probiotic properties and ability to produce enzymes and antibiotics, making it a key ingredient in enhancing productivity and health outcomes in both the agricultural and dietary sectors. The rise in livestock production and the need for cost-effective solutions in animal feed are further contributing to this growth. Additionally, the trend towards biopesticides and biofertilizers in agriculture is also boosting the demand for Bacillus Licheniformis products.

Growth Factor of the Market

The Bacillus Licheniformis market is experiencing significant growth due to a combination of factors that are reshaping consumer preferences and industrial practices. The increasing awareness regarding the benefits of probiotics and enzymes derived from natural sources has led to a higher adoption rate in various applications, particularly in agriculture and animal nutrition. Furthermore, there is a growing trend towards organic farming and sustainable agriculture, which favors the use of biological agents like Bacillus Licheniformis. The pharmaceutical sector is also recognizing the potential of this microorganism in developing new antibiotics, contributing to its market expansion. Innovations in product formulations and advancements in biotechnology are making Bacillus Licheniformis more accessible, enhancing its usability across industries. The rise in health-conscious consumers and the shift towards fermented foods further support the demand for Bacillus Licheniformis, solidifying its position in the market.

Key Highlights of the Market

• The Bacillus Licheniformis market is anticipated to reach USD 1.5 billion by 2035.
• It is projected to grow at a CAGR of 7.5% during 2025-2035.
• Increasing demand for sustainable agricultural practices significantly influences market growth.
• Growing utilization of Bacillus Licheniformis in the pharmaceutical industry is a key driver.
• Rising consumer awareness regarding health and wellness is boosting demand in the food and beverage sector.

By Product Type

Powder Form:

Powder form of Bacillus Licheniformis is one of the most widely used formats in various applications, particularly in agriculture and animal feed. The powder form allows for easy incorporation into feed formulations and agricultural products, facilitating uniform distribution and effective delivery of the beneficial microorganisms. The stability of Bacillus Licheniformis in powder form enhances its shelf life, making it a preferred choice for manufacturers and end-users. Additionally, the powder can be easily mixed with other ingredients, which is particularly beneficial in the production of biofertilizers and biopesticides. The growing trend towards natural alternatives in crop protection and animal nutrition is driving the demand for powdered Bacillus Licheniformis, as it aligns with the needs of modern sustainable farming practices.

Liquid Form:

The liquid form of Bacillus Licheniformis has gained traction due to its ease of application and effectiveness in various sectors. In agriculture, liquid formulations can be directly applied to crops or mixed with irrigation systems to ensure even distribution and rapid absorption. This form is particularly favored in large-scale agricultural operations, where efficient application methods are essential. Moreover, in the food and beverage industry, liquid Bacillus Licheniformis is used in fermentation processes, enhancing the flavor and health benefits of products. The convenience of using liquid formulations also appeals to consumers looking for ready-to-use solutions, further driving its market growth. The versatility of liquid Bacillus Licheniformis makes it a significant segment within the overall market.

Capsule Form:

Capsule form of Bacillus Licheniformis is primarily utilized in the pharmaceutical and dietary supplement sectors. This format provides a controlled dosage of probiotics, making it easier for consumers to ingest the right amount for health benefits. Capsules also protect the probiotics from environmental factors, ensuring that they remain viable until consumption. The trend towards personalized nutrition and probiotics has sparked a growing interest in capsule formulations, as they allow for targeted delivery of beneficial microorganisms. Additionally, the convenience of capsules appeals to health-conscious consumers seeking to enhance their gut health and overall well-being. As awareness of probiotics continues to rise, the capsule segment of Bacillus Licheniformis is expected to expand significantly.

Tablet Form:

Tablet form of Bacillus Licheniformis is another option that caters to the dietary supplement market. Tablets offer a convenient and portable way for consumers to benefit from the probiotic properties of Bacillus Licheniformis. The compact nature of tablets allows for easy incorporation into daily routines, making them an attractive choice for busy individuals. Moreover, advancements in tablet technology have improved the taste and dissolution rate, enhancing the overall consumer experience. As the demand for probiotics in daily diets rises, the tablet form of Bacillus Licheniformis is becoming increasingly popular among consumers looking for easy-to-consume health solutions. The ability to produce tablets with specific health claims also opens up new avenues for product differentiation in this segment.

Other Forms:

In addition to the common forms mentioned above, Bacillus Licheniformis can also be found in other innovative formulations, such as granules and emulsions, catering to specific market needs. Granules, for instance, are often used in agricultural applications for their ease of application and stability during transport. Emulsions, on the other hand, can enhance the bioavailability of the probiotic, making it more effective in various applications. The versatility in forms allows manufacturers to tailor their products to meet the unique demands of different sectors, including food, agriculture, and pharmaceuticals. This flexibility not only broadens the market reach of Bacillus Licheniformis but also contributes to its ongoing growth and acceptance across diverse industries.

By Application

Agriculture:

The agriculture sector is one of the primary applications of Bacillus Licheniformis, where it is utilized for its biocontrol and soil enhancement properties. This microorganism plays a crucial role in promoting plant health by suppressing soil-borne pathogens, thereby reducing the need for chemical pesticides. Bacillus Licheniformis enhances nutrient availability in the soil, leading to improved crop yields and quality. The rising trend towards organic farming and sustainable agricultural practices is pushing farmers to incorporate Bacillus Licheniformis into their cultivation strategies. Furthermore, the need for eco-friendly solutions in pest control is driving the adoption of biological agents like Bacillus Licheniformis, further solidifying its importance in modern agriculture.

Animal Feed:

Bacillus Licheniformis is increasingly being used in the animal feed industry due to its ability to improve gut health and enhance nutrient absorption in livestock. The incorporation of probiotics like Bacillus Licheniformis promotes a balanced gut microbiome, which is essential for the overall health and productivity of animals. This application is particularly vital in poultry and swine production, where the demand for growth performance and feed efficiency is high. The trend towards natural feed additives as alternatives to antibiotics is driving the growth of Bacillus Licheniformis in the animal feed sector. By improving the health and performance of livestock, this microorganism contributes to the sustainability and profitability of animal farming, further boosting its market presence.

Food & Beverage:

In the food and beverage industry, Bacillus Licheniformis is valued for its probiotic properties and is commonly used in fermented products. The growing consumer interest in healthy eating and functional foods has led to a rise in demand for probiotic-enriched products, making Bacillus Licheniformis a valuable ingredient. Its ability to enhance flavors and improve the shelf life of food products further adds to its appeal. As consumers become more health-conscious, there is a significant shift towards the inclusion of natural and beneficial ingredients in food and beverages, presenting a substantial opportunity for Bacillus Licheniformis. The market is expected to expand as more manufacturers explore the benefits of incorporating this microorganism into their product lines.

Pharmaceuticals:

The pharmaceutical application of Bacillus Licheniformis is focused on its potential as a source of antibiotics and probiotics for human health. Research is uncovering new therapeutic uses for this microorganism, particularly in developing treatments for gastrointestinal disorders and enhancing immune function. The growing awareness of the importance of gut health and the role of probiotics in disease prevention is driving research and product development in this area. Manufacturers in the pharmaceutical sector are increasingly exploring the use of Bacillus Licheniformis in dietary supplements, aiming to provide consumers with effective options for improving health outcomes. The convergence of healthcare and dietary supplements presents significant growth potential for Bacillus Licheniformis in the pharmaceutical market.

Others:

Besides the major applications, Bacillus Licheniformis finds use in various other sectors such as cosmetics and bioremediation. In cosmetics, it is being explored for its skin-beneficial properties, particularly for maintaining skin health and enhancing the efficacy of skincare formulations. Furthermore, Bacillus Licheniformis is being investigated for its potential in bioremediation processes, where it can help in the degradation of pollutants in the environment. The versatility of Bacillus Licheniformis across diverse applications showcases its potential to meet the evolving needs of multiple industries. This flexibility is likely to drive its consumption and expand market opportunities in the coming years.

By Distribution Channel

Direct Sales:

Direct sales channels for Bacillus Licheniformis products are crucial for manufacturers seeking to establish a direct relationship with their customers. This approach allows for better communication regarding product benefits, usage instructions, and customer support. Direct sales enable manufacturers to gather valuable feedback from end-users, which can inform product development and innovation. Additionally, by selling directly, companies can ensure better margins compared to indirect sales channels. As more consumers seek information on the origins and efficacy of products, the transparent nature of direct sales is increasingly appealing, leading to a rise in this distribution method within the Bacillus Licheniformis market.

Indirect Sales:

Indirect sales channels, including distributors and retailers, play a significant role in the Bacillus Licheniformis market by expanding the reach of products to a broader audience. These channels provide manufacturers with the infrastructure needed to distribute their products efficiently across various regions and markets. Retailers, both online and brick-and-mortar, offer consumers the convenience of purchasing Bacillus Licheniformis products easily. This distribution method is particularly effective for large-scale agricultural and animal feed applications, where bulk purchases are common. Additionally, indirect sales channels enable manufacturers to tap into established networks, facilitating market entry and customer acquisition in new regions.

By Ingredient Type

Enzymes:

Enzymes derived from Bacillus Licheniformis are a critical component in various applications, particularly in the food and beverage industry. These enzymes play a vital role in enhancing the production processes, such as fermentation and brewing, where they improve yields and flavor profiles. The demand for enzyme-based products is on the rise as manufacturers seek to optimize their processes while adhering to natural and sustainable practices. In agriculture, enzymes can enhance soil health by promoting nutrient availability, thus boosting crop productivity. The continued research into the efficacy and applications of Bacillus Licheniformis-derived enzymes is expected to drive growth in this segment, as they are recognized for their efficiency and effectiveness.

Antibiotics:

Bacillus Licheniformis is known for its ability to produce antibiotics, which are utilized to combat bacterial infections in both human health and animal husbandry. The increasing concern over antibiotic resistance has led to a renewed interest in natural antibiotics sourced from microorganisms like Bacillus Licheniformis. The pharmaceutical industry is actively exploring these antibiotics as alternatives to conventional synthetic options, aiming to provide effective treatments while minimizing resistance risks. This segment's growth is supported by ongoing research into the therapeutic potential of Bacillus Licheniformis, resulting in new antibiotic formulations with enhanced efficacy. The demand for natural alternatives in healthcare is likely to propel the antibiotic segment of this market forward.

Probiotics:

Probiotics derived from Bacillus Licheniformis are gaining popularity as consumers become increasingly aware of their health benefits, particularly for gut health. The application of probiotics in dietary supplements and functional foods is expanding as studies continue to support their effectiveness in promoting a balanced gut microbiome. This trend is particularly significant in the context of rising digestive health issues among consumers. Additionally, probiotics are being incorporated into animal feed to improve livestock health and growth performance, further driving demand. As the health and wellness industry continues to grow, probiotics from Bacillus Licheniformis will likely see increased interest and application across various sectors.

Others:

Other ingredient types derived from Bacillus Licheniformis may include various metabolites and compounds that enhance its functionality across different applications. These can be leveraged in diverse sectors, from cosmetics to environmental applications like bioremediation. The versatility of Bacillus Licheniformis allows manufacturers to explore innovative formulations and product offerings that cater to niche market demands. As research continues to uncover the potential uses of Bacillus Licheniformis, the 'Others' segment is likely to experience growth as manufacturers identify new opportunities for utilizing this microorganism in varied contexts.

By Region

The North American region is witnessing robust growth in the Bacillus Licheniformis market, driven by a combination of factors such as a strong emphasis on sustainable agricultural practices and increasing consumer demand for probiotics in food products. The United States and Canada are at the forefront of adopting biotechnological innovations, which has fostered a favorable environment for the development and commercialization of Bacillus Licheniformis products. The region is expected to maintain a significant share of the market, with a projected CAGR of 6.5% during the forecast period. This growth will be fueled by advancements in manufacturing processes and an expanding range of applications across agriculture, food, and pharmaceuticals.

Europe is also a key market for Bacillus Licheniformis, with countries like Germany, France, and the United Kingdom leading the charge in both demand and research initiatives. The European market is characterized by a strong regulatory framework that supports the use of probiotics and biopesticides, creating opportunities for Bacillus Licheniformis applications. The increasing focus on organic farming and the desire to reduce chemical inputs in agriculture are pivotal drivers of market growth in this region. As consumer preferences continue to shift towards natural and sustainable products, the demand for Bacillus Licheniformis is expected to rise, supporting a CAGR of 8% during the forecast period.

Opportunities

The Bacillus Licheniformis market is poised for substantial opportunities driven by the growing trend towards sustainability and organic practices in agriculture. As consumers and farmers alike prioritize environmentally friendly solutions, the demand for biological agents that promote plant health and soil fertility is rising. Bacillus Licheniformis serves as an effective alternative to chemical fertilizers and pesticides, enabling farmers to adhere to organic standards while improving crop yields. The increasing government support for sustainable agricultural initiatives further creates a conducive environment for market growth. By capitalizing on these trends, manufacturers can develop innovative products that cater to the evolving needs of farmers seeking to implement eco-friendly practices in their operations.

Moreover, the burgeoning interest in health and wellness among consumers presents significant opportunities for Bacillus Licheniformis in the food and pharmaceutical sectors. The rising awareness regarding the benefits of probiotics is driving an increase in demand for functional foods enriched with beneficial microorganisms. As research continues to support the health claims associated with Bacillus Licheniformis, manufacturers can explore new formulations in dietary supplements and food products. This growing market for health products presents a lucrative opportunity for companies to expand their product offerings and reach health-conscious consumers, further propelling the Bacillus Licheniformis market forward.

Threats

Despite the positive outlook for the Bacillus Licheniformis market, several threats could hinder its growth trajectory. One of the primary concerns is the increasing competition from synthetic alternatives, which may offer immediate results in agricultural and industrial applications. While natural products like Bacillus Licheniformis provide long-term benefits, the speed and convenience of synthetic options can appeal to consumers and manufacturers seeking quick solutions. Additionally, the regulatory landscape surrounding the use of probiotics and biological agents can be complex and challenging to navigate, particularly in different regions. Companies must stay abreast of changing regulations to ensure compliance, which can pose a significant barrier to market entry and expansion.

Another major threat is the potential for contamination or inconsistent quality of Bacillus Licheniformis products during manufacturing and distribution processes. If consumers encounter ineffective or contaminated products, it could lead to a loss of trust in natural alternatives. Furthermore, the growing trend of antibiotic resistance poses a challenge for the pharmaceutical application of Bacillus Licheniformis, as the healthcare community continually seeks new solutions that address this pressing issue. Companies in the Bacillus Licheniformis market must proactively focus on research and development to mitigate these risks and maintain a competitive edge.

Competitor Outlook

• BASF SE
• Novozymes A/S
• DuPont de Nemours, Inc.
• Chr. Hansen Holding A/S
• Royal DSM N.V.
• AB Enzymes GmbH
• Syngenta AG
• BioCare Copenhagen A/S
• Biolchim S.p.A.
• Kemin Industries, Inc.
• Adisseo France S.A.S.
• Puratos Group
• Eligo Bioscience
• AquaBounty Technologies, Inc.
• Biotech Foods S.L.

The competitive landscape of the Bacillus Licheniformis market is characterized by a diverse range of players operating across various segments, including agriculture, food and beverage, and pharmaceuticals. These companies are actively engaged in research and development initiatives to enhance product efficacy and broaden application scopes. Major players are investing in innovation to create advanced formulations that meet the evolving needs of consumers, particularly in the context of health and sustainability. Collaborations and partnerships among industry stakeholders are also becoming increasingly prevalent, as companies seek to leverage synergies and expand their market presence. This competitive environment is likely to drive improvements in product quality, performance, and pricing strategies.

Among the key competitors, BASF SE stands out as a leading player, focusing on developing sustainable solutions across various industries. The company has made significant investments in biotechnology, including Bacillus Licheniformis applications, to support agricultural productivity and promote environmental sustainability. Another major competitor, Novozymes A/S, is renowned for its enzyme production and has been actively exploring the benefits of Bacillus Licheniformis in various applications. Their commitment to sustainability and innovative practices positions them as a formidable player in the market, continuously working to meet consumer demand for natural solutions.

Furthermore, DuPont de Nemours, Inc. has been significant in the Bacillus Licheniformis landscape, particularly through its focus on health and wellness applications. The company leverages its extensive research capabilities to develop probiotics and other beneficial microorganisms for consumer health, driving growth in this sector. Chr. Hansen Holding A/S and Royal DSM N.V. also play pivotal roles in advancing the use of Bacillus Licheniformis, with their emphasis on sustainable practices and commitment to enhancing food and feed quality. As competition intensifies, these companies must continue to innovate and adapt to changing consumer preferences and regulatory landscapes to maintain their positions in the Bacillus Licheniformis market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 BASF SE
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Syngenta AG
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Novozymes A/S
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Puratos Group
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Royal DSM N.V.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 AB Enzymes GmbH
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Biolchim S.p.A.
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Eligo Bioscience
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Biotech Foods S.L.
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Adisseo France S.A.S.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 BioCare Copenhagen A/S
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Kemin Industries, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Chr. Hansen Holding A/S
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 DuPont de Nemours, Inc.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 AquaBounty Technologies, Inc.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Bacillus Licheniformis Sales Market, By Application
    • 6.1.1 Agriculture
    • 6.1.2 Animal Feed
    • 6.1.3 Food & Beverage
    • 6.1.4 Pharmaceuticals
    • 6.1.5 Others
  • 6.2 Bacillus Licheniformis Sales Market, By Product Type
    • 6.2.1 Powder Form
    • 6.2.2 Liquid Form
    • 6.2.3 Capsule Form
    • 6.2.4 Tablet Form
    • 6.2.5 Other Forms
  • 6.3 Bacillus Licheniformis Sales Market, By Ingredient Type
    • 6.3.1 Enzymes
    • 6.3.2 Antibiotics
    • 6.3.3 Probiotics
    • 6.3.4 Others
  • 6.4 Bacillus Licheniformis Sales Market, By Distribution Channel
    • 6.4.1 Direct Sales
    • 6.4.2 Indirect Sales

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Bacillus Licheniformis Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Bacillus Licheniformis Sales market is categorized based on

By Product Type

• Powder Form
• Liquid Form
• Capsule Form
• Tablet Form
• Other Forms

By Application

• Agriculture
• Animal Feed
• Food & Beverage
• Pharmaceuticals
• Others

By Distribution Channel

• Direct Sales
• Indirect Sales

By Ingredient Type

• Enzymes
• Antibiotics
• Probiotics
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• BASF SE
• Novozymes A/S
• DuPont de Nemours, Inc.
• Chr. Hansen Holding A/S
• Royal DSM N.V.
• AB Enzymes GmbH
• Syngenta AG
• BioCare Copenhagen A/S
• Biolchim S.p.A.
• Kemin Industries, Inc.
• Adisseo France S.A.S.
• Puratos Group
• Eligo Bioscience
• AquaBounty Technologies, Inc.
• Biotech Foods S.L.